Aim We investigated the relationship between weight change and related factors in subjects
with type 2 diabetes mellitus (T2DM) treated with liraglutide versus comparator diabetes …

Importance Weight loss of 5% to 10% can improve type 2 diabetes and related
comorbidities. Few safe, effective weight-management drugs are currently available …

Background This pilot study evaluated whether adding phentermine to liraglutide would
induce further weight loss in participants who had previously lost weight with liraglutide …

Aims/hypothesis The best treatment strategy for a patient with type 2 diabetes who shows
pronounced weight gain after the introduction of insulin treatment is unclear. We determined …

OBJECTIVE Most individuals with type 2 diabetes also have obesity, and treatment with
some diabetes medications, including insulin, can cause further weight gain. No approved …

Background The frequency of obesity has risen dramatically in recent years but only few
safe and effective drugs are currently available. We assessed the effect of liraglutide on …

Objective: To investigate whether the efficacy and safety of liraglutide 3.0 mg differed
between two subgroups, BMI 27 to< 35 and BMI≥ 35 kg/m², in individuals without and with …

Background Obesity is a chronic disease with serious health consequences, but weight loss
is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagon-like …

The GLP-1 receptor agonist Liraglutide is effective in reducing HbA1c in type 2 diabetic
(T2D) patients. In addition, treatment with Liraglutide is associated with significant weight …

Introduction: Obesity is a global health challenge, and pharmacologic options are emerging.
Once daily subcutaneous administration of 3 mg liraglutide, a glucagon like peptide-1 …